Press release
Global Antidepressant Drugs Market: Opportunities and Forecasts (2018-2023)
Globally, the market for antidepressant drugs mask has been growing at a swift pace on the back of rising prevalence mental disorders, rising healthcare awareness and rising disposable incomes. Apart from these factors, rising healthcare facilities, increasing number of psychiatrist as well as surging number of hospital and clinics and burgeoning growth in Asia Pacific market is impelling growth in the market.A comprehensive research report that analyses the antidepressant drugs market and the drugs market by Class - Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Selective Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Benzodiazepines, Antipsychotics and Novel Agents, the report also assesses the sales of antidepressant drugs by sales channels - Hospital & Clinics, Retail Pharmacies, Others.
A research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Antidepressant Drugs Market By Region (North America, Europe, Asia Pacific and Rest of the world) and By Country (U.S., Canada, Germany, United Kingdom, India, Japan China, Brazil, Saudi Arabia) for the historical period of 2013-2017 and forecast period of 2018-2023.
According to Azoth Analytics research report “Global Antidepressant Drugs Market – Analysis By Drugs Class, By Sales Channel, By Region, By Country: Opportunities and Forecasts (2018-2023) - By Region (APAC, N. America, Europe, RoW), By Country (US, Canada, UK, Germany, China, India, Japan, Brazil, South Arabia)”, the global market is projected to display a robust growth represented by a CAGR of 3.12% during 2018 – 2023.
The Selective Serotonin Reuptake Inhibitors (SSRIs) drug class has witnessed growth at a noteworthy rate over the past few years and in the forecast period on account of rising health awareness related to mental disorders particularly in developing countries including China, India, etc., rising healthcare expenditure as well as rising disposable incomes. Amongst the regions, North America accounts for the largest regional share in the global antidepressant drugs in 2017.
The report titled “Global Antidepressant Drugs Market – Analysis By Drugs Class, By Sales Channel, By Region, By Country: Opportunities and Forecasts (2018-2023) - By Region (APAC, N. America, Europe, RoW), By Country (US, Canada, UK, Germany, China, India, Japan, Brazil, South Arabia)” has covered and analysed the potential of Global Antidepressant Drugs Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global antidepressant drugs market. Additionally, the report also highlights market entry strategies for various companies across the globe.
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Antidepressant Drugs Market: Analysis By Drugs Class (Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Selective -Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Benzodiazepines, Antipsychotics and Novel Agents), By Sales Channels (Hospital & Clinics, Retail Pharmacies, Others) for the Regions (North America, Europe, Asia Pacific and Rest of the world) and for Countries (U.S., Canada , Germany, United Kingdom, India, Japan China, Brazil, Saudi Arabia).
CS – 55, Third Floor, Ansal Plaza, Vaishali,
Ghaziabad U.P., India
Mail: info@azothanalytics.com
Azoth Analytics is a business research and analytics firm that creates in-depth research reports and provides customized research solutions and consultancy services. Verticals in which Azoth Analytics specializes include healthcare and pharmaceutical, oil and gas, retail, chemicals, automotive, FMCG, food & beverages and technology. Azoth creates comprehensive and in-depth research reports by recording, interpreting and analyzing information. Strategic market sizing and data dredging techniques include secondary research, and primary research (interviews with management personnel and industry experts).
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Antidepressant Drugs Market: Opportunities and Forecasts (2018-2023) here
News-ID: 949099 • Views: …
More Releases from Azoth Analytics Pvt. Ltd.

Solid Oxide Fuel Cell Market Factbook (2023 Edition)
Azoth Analytics has released a research report "Solid Oxide Fuel Cell Market Factbook (2023 Edition)" which provides a complete analysis of the Global Solid Oxide Fuel Cells industry By Type (Tubular, Planar), Applications (Portable, Transport, Stationary) and By End User (Residential, Transportation, Commercial, Industrial, Military and Defense, Data Centers). The SOFC market has been analyzed by Value (USD Million) and Volume (Installed MW) at the global level, for four regions…

Luxury Goods Market Size to Reach $385.20 Billion by 2028
Azoth Analytics Releases New Luxury Goods Market Research Report: Market Size to Reach $385.20 Billion by 2028
Azoth Analytics, a leading market research firm, has released a new report on the global luxury goods market. The report provides a comprehensive analysis of the market, including trends, drivers, challenges, and opportunities. It covers various segments of the market, including fashion and leather goods, watches and jewelry, cosmetics and fragrances, and others. The…
More Releases for Drugs
Generic Drugs Market Application Anti-Infective Drugs, Anti-Arthritis Drugs, Ant …
Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the branded…
Cytotoxic Drugs Market Growing Demand for Antimetabolite Drugs
According to Precision Business Insights (PBI), the latest report, the cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022 and is poised to grow at a significant CAGR of 2.2% over 2022-2028. The primary drivers of the expansion of the global cytotoxic drugs market include the increasing prevalence of cancer diseases, the increasing use and approval of cytotoxic drugs, and the increasing consumption of alcohol…
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information:
https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html
Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$…